Littlefish- IART
I understand about the problems the company has, but they are still in business, just had a successful acquisition, just opened up their new factory in MA to make the old tissue devices in 2026, that were recalled in 2022, and are guiding for $2.25 in adjusted eps for 2025. Now that means they're selling for a 5.5 PE on 2025 expected eps, and much lower for 2026 vs 27 for the sector. Also now that you mention the debt, I recall on the CC, that the CFO said they feel their debt ratios are high, but within acceptable parameters for the industry. The bottom line for me is simple- have we seen the bottom for this company around $11 ? I believe by 2026, the stock could be a triple or greater- time will tell.
Market Data 
Markets 
AI
